The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 453 | 61,264 | SH | SOLE | 61,264 | 0 | 0 | ||
| ALCENTRA CAP CORP | COM | 01374T102 | 487 | 75,303 | SH | SOLE | 75,303 | 0 | 0 | ||
| ALPS ETF TR | ALERIAN MLP | 00162Q866 | 3,596 | 411,873 | SH | SOLE | 411,873 | 0 | 0 | ||
| ARES CAP CORP | COM | 04010L103 | 273 | 17,553 | SH | SOLE | 17,553 | 0 | 0 | ||
| ARQULE INC | COM | 04269E107 | 345 | 124,435 | SH | SOLE | 124,435 | 0 | 0 | ||
| BERKSHIRE HATHAWAY INC DEL | CL B NEW | 084670702 | 1,901 | 9,312 | SH | SOLE | 9,312 | 0 | 0 | ||
| CM FIN INC | COM | 12574Q103 | 6,427 | 1,028,355 | SH | SOLE | 1,028,355 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM NEW | 12648L601 | 91 | 123,941 | SH | SOLE | 123,941 | 0 | 0 | ||
| DICERNA PHARMACEUTICALS INC | COM | 253031108 | 149 | 13,948 | SH | SOLE | 13,948 | 0 | 0 | ||
| EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 444 | 43,709 | SH | SOLE | 43,709 | 0 | 0 | ||
| FAR PT ACQUISITION CORP | COM CL A | 30734W109 | 262 | 27,116 | SH | SOLE | 27,116 | 0 | 0 | ||
| FS KKR CAPITAL CORP | COM | 302635107 | 421 | 81,348 | SH | SOLE | 81,348 | 0 | 0 | ||
| GARRISON CAP INC | COM | 366554103 | 7,830 | 1,217,722 | SH | SOLE | 1,217,722 | 0 | 0 | ||
| INTEC PHARMA LTD JERUSALEM | SHS | M53644106 | 318 | 42,236 | SH | SOLE | 42,236 | 0 | 0 | ||
| JBG SMITH PPTYS | COM | 46590V100 | 778 | 22,349 | SH | SOLE | 22,349 | 0 | 0 | ||
| KALA PHARMACEUTICALS INC | COM | 483119103 | 6,639 | 1,357,639 | SH | SOLE | 1,357,639 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 461 | 32,828 | SH | SOLE | 32,828 | 0 | 0 | ||
| MARINUS PHARMACEUTICALS INC | COM | 56854Q101 | 176 | 61,443 | SH | SOLE | 61,443 | 0 | 0 | ||
| MARKER THERAPEUTICS INC | COM | 57055L107 | 296 | 53,329 | SH | SOLE | 53,329 | 0 | 0 | ||
| MEI PHARMA INC | COM NEW | 55279B202 | 9,132 | 3,459,124 | SH | SOLE | 3,459,124 | 0 | 0 | ||
| MOLECULAR TEMPLATES INC | COM | 608550109 | 6,562 | 1,624,241 | SH | SOLE | 1,624,241 | 0 | 0 | ||
| SCYNEXIS INC | COM | 811292101 | 2,083 | 4,325,000 | SH | SOLE | 4,325,000 | 0 | 0 | ||
| SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 3,501 | 14,010 | SH | SOLE | 14,010 | 0 | 0 | ||
| SPRING BK PHARMACEUTICALS IN | COM | 849431101 | 219 | 21,034 | SH | SOLE | 21,034 | 0 | 0 | ||
| STRONGBRIDGE BIOPHARMA PLC | SHS USD | G85347105 | 29,586 | 6,604,065 | SH | SOLE | 6,604,065 | 0 | 0 | ||